eNOS associates with Caveolin-1

Stable Identifier
R-HSA-203712
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Caveolin-1 is the primary negative regulatory protein for eNOS. Caveolin-1 binding to eNOS compromises its ability to bind Calmodulin (CaM), thereby inhibiting enzyme activity. The major binding region of caveolin-1 for eNOS is within amino acids 60-101 and to a lesser extent, amino acids 135-178 (Garcia-Cardena et al. 1997; Ghosh et al. 1998).
Literature References
PubMed ID Title Journal Year
9325253 Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo.

Sessa, WC, Skidd, PM, Lisanti, MP, Masters, BS, Garcia-Cardena, G, Li, S, Martasek, P, Couet, J

J Biol Chem 1997
8798458 Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.

Michel, T, Kobzik, L, Belhassen, L, Smith, TW, Feron, O, Kelly, RA

J Biol Chem 1996
9712842 Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis.

Crooks, C, Lisanti, MP, Gachhui, R, Ghosh, S, Wu, C, Stuehr, DJ

J Biol Chem 1998
11498544 Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

Schedl, A, Kasper, M, Verkade, P, Elger, M, Luft, FC, Menne, J, Kurzchalia, TV, Lindschau, C, Lauterbach, B, Lohn, M, Haller, H, Mende, F, Drab, M

Science 2001
Participants
Participates
Catalyst Activity

nitric-oxide synthase inhibitor activity of CAV1 [lipid droplet]

Orthologous Events
Authored
Reviewed
Created
Cite Us!